
MLN 3897
CAS No. 1010731-97-1
MLN 3897( AVE 9897 )
Catalog No. M10069 CAS No. 1010731-97-1
MLN 3897 is a potent, specific and orally active antagonist of CCR1 with IC50 of 0.8 nM in competition binding assays.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 404 | Get Quote |
![]() ![]() |
10MG | 608 | Get Quote |
![]() ![]() |
25MG | 1039 | Get Quote |
![]() ![]() |
50MG | 1555 | Get Quote |
![]() ![]() |
100MG | 2336 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameMLN 3897
-
NoteResearch use only, not for human use.
-
Brief DescriptionMLN 3897 is a potent, specific and orally active antagonist of CCR1 with IC50 of 0.8 nM in competition binding assays.
-
DescriptionMLN 3897 is a potent, specific and orally active antagonist of CCR1 with IC50 of 0.8 nM in competition binding assays, 500-fold selectivity over CCR5; inhibits osteoclastogenesis and OC activity by impairing multinucleation and by down-regulation of c-fos signaling, inhibits osteoclastogenesis and OC activity by impairing multinucleation and by down-regulation of c-Fos signaling; demonstrates potential for the treatment of multiple sclerosis and rheumatoid arthritis.Multiple Sclerosis Phase 1 Discontinued.
-
In Vitro——
-
In Vivo——
-
SynonymsAVE 9897
-
PathwayGPCR/G Protein
-
TargetChemokine Receptor
-
RecptorChemokine Receptor
-
Research AreaInflammation/Immunology
-
IndicationMultiple Sclerosis
Chemical Information
-
CAS Number1010731-97-1
-
Formula Weight535.125
-
Molecular FormulaC32H39ClN2O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO[C@@]1(C2=CC=C(Cl)C=C2)C(C)(C)CN(CC/C=C3C(C=CCN4)=C4COC5=CC=C(C(C)(O)C)C=C\35)CC1
-
Chemical Name(S,E)-4-(4-chlorophenyl)-1-(3-(7-(2-hydroxypropan-2-yl)-2,11-dihydrobenzo[6,7]oxepino[3,4-b]pyridin-5(1H)-ylidene)propyl)-3,3-dimethylpiperidin-4-ol
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Gilchrist A, et al. Br J Pharmacol. 2014 Nov;171(22):5127-38.
2. Vallet S, et al. Blood. 2007 Nov 15;110(10):3744-52.
3. Lu C, et al. J Pharmacol Exp Ther. 2010 Feb;332(2):562-8.
4. Vergunst CE, et al. Arthritis Rheum. 2009 Dec;60(12):3572-81.
molnova catalog



related products
-
IT1t
A highly potent, selective, orally bioavailable CXCR4 inhibitor with binding IC50 of 8 nM for hCXCR4, IC50 of 1.1 nM in Ca2+-mobilization assays.
-
CCR10 antagonist 1
CCR10 antagonist 1 is a potent, selective CCR10 antagonist with IC50 of 690 nM.
-
CCX140
A potent, selective, orally bioavailable CCR2 antagonist with Kd of 2.3 nM for hCCR2.